Sign in

Astrid Pentz-Murr

@astridpm.bsky.social
125 followers 387 following 13 posts

Here I care about #AMR, knowledge sharing, maternal health & more. Current real-life obsession as a good millennial: running. Working on antimicrobial R&D education @gardp.bsky.social --> check out revive.gardp.org .~* Views expressed are my own *~.

PostsRepliesMedia
Reposted by Astrid Pentz-Murr
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 27/07/2026
🚨 This is BIG! The Thai FDA has approved NUZOLVENCE® (zoliflodacin), a first-in-class oral antibiotic for the treatment of uncomplicated urogenital gonorrhoea, just 6 months after its initial approval by the US FDA. 🔗 gardp.org/thai-fda-app...
122
Reposted by Astrid Pentz-Murr
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 20/04/2026
Missed #ACC2026? All sessions are now available to watch. They cover how antibacterial R&D moves from early research to development, and where the gaps are. ▶️Watch here: acc-conference.com#agenda
001
Reposted by Astrid Pentz-Murr
INCATE @incate.bsky.social · 15/04/2026
We heard you 👀 With the long weekend coming up, many couldn’t join Entrepreneurs Club #6 — so we’ve moved it! 📅 May 28 | 🕔5pm CEST Join us for “What does it take to be an entrepreneur?” ! Save your spot ➡️ www.eventbrite.ch/e/entreprene... #EntrepreneursClub #StartupLife
eventbrite.ch
Entrepreneurs Club #6: "What does it take to be an entrepreneur?"
The 6th INCATE Entrepreneurs Club brings together three compelling perspectives to uncover what defines entrepreneurship.
011
Astrid Pentz-Murr @astridpm.bsky.social · 14/04/2026
If you're at ESCMID Global, please come meet my colleague Shirine at booth G71 to learn more about #REVIVE and share your ideas how we can continue to support the antimicrobial R&D community. revive.gardp.org
revive.gardp.org
Home
Welcome to REVIVE! For many years, antimicrobial researchers left the field or re-focused their activities risking losing invaluable experience and knowledge crucial for the discovery, research and de...
020
Reposted by Astrid Pentz-Murr
European Centre for Disease Prevention and Control @ecdc.europa.eu · 01/04/2026
Did you know? 🧵 1/3
2124
Reposted by Astrid Pentz-Murr
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 02/04/2026
🆕A newly published piece in @natureportfolio.nature.com examines the NeoSep1 trial expansion led by GARDP Aiming to enrol 3,000+ newborns across Africa and Asia, the trial will generate evidence that clinicians can use immediately, leading to better outcomes for newborns. 🔗 bit.ly/4vbZ4LY
nature.com
NeoSep1 trial widens to find better sepsis treatment for newborns
Researchers test tailored antibiotic combinations for babies in African hospitals to boost survival.
112
Astrid Pentz-Murr @astridpm.bsky.social · 27/02/2026
A great milestone with real public health impact! 🎉
010
Astrid Pentz-Murr @astridpm.bsky.social · 18/02/2026
Our education and outreach programme for antimicrobial researchers would be nothing without the generous, voluntary contributions of countless leading experts. Thank you! #knowledgesharing #AMR
020
Reposted by Astrid Pentz-Murr
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 18/02/2026
🌍🔬 In 2025, REVIVE welcomed 17 new experts to its global network supporting antimicrobial R&D. Together with over 200 specialists across discovery, development and access, they help accelerate innovation against drug-resistant infections. #AMR #AntibioticInnovation #GlobalHealth #REVIVE
222
Reposted by Astrid Pentz-Murr
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 15/02/2026
📢 NEWS: Kenya joins GARDP’s NeoSep1 Part 2 trial on #NeonatalSepsis. The trial has started enrolling newborn babies with sepsis at Kilifi County Hospital (Kilifi) Coast General Teaching & Referral Hospital (Mombasa) and Mbagathi Hospital (Nairobi).
123
Reposted by Astrid Pentz-Murr
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 12/02/2026
🌍🏆 Dr Manica Balasegaram has been named one of TIME’s 100 most influential people in health for advancing and expanding access to new antibiotic treatments so as to tackle antimicrobial resistance. 🔗 Read the TIME feature: time.com/collections/... #TIME100
153
Reposted by Astrid Pentz-Murr
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 05/02/2026
🔴💥 Session Seven moment “From erections to resurrection — not womb to tomb.” With that striking opening, Dr Teodora Elvira C. Wi reframes the conversation on STIs, maternal infections and neonatal sepsis, and why early action matters. 🎦Watch the rest of the session LIVE: bit.ly/3LVHIkF #ACC2026
111
Astrid Pentz-Murr @astridpm.bsky.social · 05/02/2026
Excited to learn more in this session! More research including pregnant and breastfeeding women is urgently needed.
101
Reposted by Astrid Pentz-Murr
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 04/02/2026
“No one should die from TB.” Dr Wanatpreeya Phongsamart emphasized that equity in TB care means prioritizing pregnant women and children, who face high mortality yet remain underrepresented in research and trials🤱👶 💭🔗 Join us: bit.ly/3NTXxZG #ACC2026
101
Reposted by Astrid Pentz-Murr
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 04/02/2026
3⃣🚀Session Three has just started at #ACC2026 The focus turns to preclinical antimicrobial development, with talks exploring lysin biotherapeutics, anti-virulence approaches and new adjunct therapies to tackle drug-resistant infections. 🎥 Join us now: portalapp.bsac.eventsair.com/VirtualAtten...
211
Reposted by Astrid Pentz-Murr
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 04/02/2026
🔴 Keynote now live at #ACC2026 Topic: Optimising multinational clinical trials with antimicrobials and the critical role of clinical trial networks 🧬🌍 Featuring Prof David Paterson, National University of Singapore and ADVANCE-ID. 🔗 bit.ly/4rmSteA @advance-id.bsky.social
111
Reposted by Astrid Pentz-Murr
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 03/02/2026
📣ACC2026 kicks off tomorrow! Join a global, online and open-access conference our antimicrobial chemotherapy, AMR and the future of antibiotic innovation. 🗓️ 4–5 Feb 2026 | 🌍 Online 🔗 Last chance to register: eventsair.pulse.ly/35puv6u0m6 #ACC2026
021
Reposted by Astrid Pentz-Murr
CARB-X @carb-x.bsky.social · 02/02/2026
Visit CARB-X’s virtual booth at ACC 2026 from Feb. 4-5 to learn more about our work! This free, virtual event is RCPath CPD approved for 8 credits. Earn continuing education credits and learn about antimicrobial drug discovery and clinical trial networks. #IDSky 🧪 🔗 Register: bit.ly/4t29ooI
011
Astrid Pentz-Murr @astridpm.bsky.social · 02/02/2026
The open-access Antimicrobial Chemotherapy Conference is more than “just” interesting presentations and discussions by leading experts! You can also explore and meet key organizations in #antimicrobialR&D! ⏩Full list in next post 📅4&5 Feb ✍️Register: acc-conference.com
110
Astrid Pentz-Murr @astridpm.bsky.social · 30/01/2026
If you haven't registered for our open-access virtual Antimicrobial Chemotherapy Conference next week, You. Are. Missing. Out! The speaker line-up is just top-notch! I mean, just look at this: acc-conference.com 🤩 #AMR #antimicrobialR&D #openaccess #ACC2026
101
Astrid Pentz-Murr @astridpm.bsky.social · 23/01/2026
A little sad that I have totally missed the first ever #WorldPPHDay but great to see that there is action! I was very unlucky to almost "manage" to die from PPH in a rich country like Switzerland, but I was SO lucky to have access to all care, tools, knowledge and medicines needed to keep me alive.
021
Astrid Pentz-Murr @astridpm.bsky.social · 23/01/2026
This post is brought to you by: BLOOD 🩸 As I am nearing the 4th anniversary of almost dying from #postpartumhaemorrhage, I am thrilled to see that blood donation criteria in Switzerland will change from 1 Feb, allowing more people to become donors. I hope to be one of them soon! shorturl.at/KstxJ
shorturl.at
More people in Switzerland can give blood from February
The criteria for blood donations in Switzerland will be relaxed from February 1.
020
Reposted by Astrid Pentz-Murr
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 21/01/2026
🚀 ACC2026 is coming up soon This free, global, online conference brings together leading minds and experts to explore what’s next for antimicrobial chemotherapy. Co-organized by GARDP and BSAC 📅 4–5 Feb 2026 |🌍 Online 🔗 Register now: bit.ly/4pSEdt7 @bsacandjac.bsky.social @advance-id.bsky.social
004
Reposted by Astrid Pentz-Murr
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 20/10/2025
📢 Exciting news! Selected articles from our Antimicrobial Viewpoints series will now be co-published in CMI Communications, @escmid.bsky.social's open-access journal. This collaboration will expand the reach and amplify the impact of these articles within the antimicrobial R&D community.
175
Reposted by Astrid Pentz-Murr
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 17/06/2025
💻📱 AntibioticDB Relaunched: New Functions, More Compounds, & Richer Data to Accelerate Antibiotic Discovery 💊 GARDP’s upgraded open-access database is a go-to tool for researchers, developers & innovators in the antibiotic space. Start exploring🔗 revive.gardp.org/antibioticdb/ #REVIVE
012